Intellicheck to Present at 6th Annual Liolios Gateway Conference in San Francisco
Aug 30, 2017 12:17 pm UTC| Business
JERICHO, N.Y., Aug. 30, 2017 -- Intellicheck (NYSE American:IDN), an industry leader in delivering real-time threat identification and identification authentication that provides the antivirus to the epidemic of...
Arkansas Department of Education Approves Istation for Grades K–2
Aug 30, 2017 12:13 pm UTC| Business
Dallas, Aug. 30, 2017 -- Istation, an industry leader in educational technology, has been awarded a statewide contract with the Arkansas Department of Education. Under the terms of the agreement, Istation’s formative...
Travelex Insurance Services and Berkshire Hathaway Travel Protection form Strategic Relationship
Aug 30, 2017 12:12 pm UTC| Business
OMAHA, Neb., Aug. 30, 2017 -- Travelex Insurance Services (Travelex) and Berkshire Hathaway Specialty Insurance Company’s Berkshire Hathaway Travel Protection (BHTP) have formed a strategic relationship to provide...
EMK Skin Care Introduces ‘24K Gold Peeling Gel’
Aug 30, 2017 12:11 pm UTC| Business
BEVERLY HILLS, Calif., Aug. 30, 2017 -- Prestige skin care line, EMK Beverly Hills has collaborated with a renowned anti-aging physician to introduce an all-new at-home skin peel. The 24K Gold Peeling Gel is the...
Aug 30, 2017 12:05 pm UTC| Business
BEIJING, Aug. 30, 2017 -- ATA Inc. ("ATA" or the "Company") (Nasdaq:ATAI), a leading provider of advanced testing technologies and testing-related services in China, today announced that its Board of Directors (the...
MaxLinear, Inc. to Present at Upcoming Financial Conferences
Aug 30, 2017 12:05 pm UTC| Business
CARLSBAD, Calif., Aug. 30, 2017 -- MaxLinear, Inc. (NYSE:MXL), a leading provider of radio-frequency, mixed-signal and high-performance analog integrated circuits for the connected home, wired and wireless...
Catalyst Pharmaceuticals Provides Update on the Status of its Firdapse Development Activities
Aug 30, 2017 12:03 pm UTC| Business
-- FDA grants Special Protocol Assessment agreement for Phase 3 MuSK-MG trial -- -- Enrollment for second Phase 3 trial for LEMS nearing completion -- -- Expected NDA submission for Firdapse moves from end of 2017 to...